Sec. 4. (a) This chapter does not constitute an endorsement of amygdalin (laetrile) for the treatment of a malignancy, a disease, an illness, or a physical condition.
(b) This chapter does not prevent a physician from prescribing amygdalin (laetrile) as a dietary supplement to a patient not suffering from a known malignancy, disease, illness, or physical condition upon execution of the written informed request.
[Pre-1993 Recodification Citation: 16-8-8-4.]
As added by P.L.2-1993, SEC.25.
Structure Indiana Code
Article 42. Regulation of Food, Drugs, and Cosmetics
Chapter 23. Drugs: Use of Amygdalin (Laetrile)
16-42-23-1. Health Care Facilities; Restrictions on Use
16-42-23-2. Disciplinary Action Against Attending Physician
16-42-23-3. Prescription or Administration Permitted With Written Informed Request
16-42-23-4. Construction of Chapter
16-42-23-5. Written Informed Request Form
16-42-23-6. Regulation of Use, Sale, Prescription, Manufacture, or Distribution Within State
16-42-23-7. Required Manufacture, Sale, Distribution, or Prescription